Article
Crystal structure of HLA-DP2 and implications for chronic beryllium disease.
Proceedings of the National Academy of Sciences of the United States of America - 20 Apr 2010
Dai Shaodong, Murphy Guinevere A, Crawford Frances, Mack Douglas G, Falta Michael T, Marrack Philippa, Kappler John W, Fontenot Andrew P
Abstract excerpt
Chronic beryllium disease (CBD) is a fibrotic lung disorder caused by beryllium (Be) exposure and is characterized by granulomatous inflammation and the accumulation of Be-responsive CD4(+) T cells in the lung. Genetic susceptibility to CBD has been associated with certain alleles of the MHCII molecule HLA-DP, especially HLA-DPB1*0201 and other alleles that contain a glutamic acid residue at position 69 of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
